CTTI (Clinical Trials Transformation Initiative) is a public-private partnership founded by the U.S. Food and Drug Administration and Duke University to identify practices that will improve the quality and efficiency of clinical trials. Oblique created a progressive new identity for the organization with a creative and engaging design. The new logo expresses collaboration, intelligence and quality — characteristics that our team carried through via a new website, stationery, PPT Presentation and sales kit.